chrisvoncsefalvay/vaers-outcomes huggingface dataset:
1 week after getting her second dose of Moderna, one day she woke up feeling very dizzy.  She went to go see her PCP where they said it was vertigo and could have been possibly be due to the covid vaccine.  She received medicine from the provider for the vertigo but it has now been 2 months since receiving the vaccine and she still gets vertigo when she wakes up in the morning, when she turns her head to the right , reaches down, or any fast head movements.
Information has been received from a physician concerning a 12 month old black female with asthma who on the morning of 14-Jul-2003 was vaccinated intramuscularly in the left arm with a first dose of varicella virus vaccine live (lot #0593U). On the morning of 14-Jul-2003 the patient was also vaccinated intramuscularly with a first dose of measles virus vaccine live (Moraten) (+) mumps virus vaccine live (+) rubella virus vaccine live (lot # 642182/0774M), and a third dose given intramuscularly of pneumococcal 4 6B 9V 14 18C 19F 23 F conj vaccine (CRM197) (lot #493899). There was no illness at the time of vaccination. There were no adverse events following previous vaccinations. On the afternoon of 31-Jul-2003 the patient "broke out" into a mild case of chicken pox (physician also reported this as "vaccinia"). It progresses over the next week with some itching. There was no fever. The physician did not know if it was due to the vaccine or from a wild virus. Unspecified medical attention was sought and no prescription drug was required. No diagnostic studies were performed. No product quality complaint was involved. On 10-Aug-2003, after 10 days, the patient recovered. No further information is expected.
Shingles along her waist; got a lot of pain; she is wondering and actually scary; This is a spontaneous report from a contactable consumer reported for her sister (Patient).  A female patient of unspecified age received first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number and expiry date was not reported), via an unspecified route of administration, on an unspecified date in 2021, as DOSE 1, SINGLE for COVID-19 immunization and second dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number and expiry date was not reported), via an unspecified route of administration, on an unspecified date in Feb2021, as DOSE 2, SINGLE for COVID-19 immunization. The patient medical history included Pre-diabetes. Concomitant medication included ATORVASTATIN CALCIUM (lipitor). The reporter stated that they called on behalf of their sister. She actually coming here to get the third dose (Booster) of Pfizer vaccine (Covid-19 Vaccine) but she actually has Shingles along her waist, got a really a lot of pain. The reported stated that they have two questions, she is wondering whether if she can get Booster shot, she is over 65, so she is qualified, but she is wondering because she still has shingles, so is that ok to get the vaccine now. The other question, want to ask because all the Doctors told her shingles probably caused by previous Pfizer Covid-19 Vaccine (first and second dose) that is actually scary and they did not if that is true or not and stated that it was 2 months ago in 2021and asked is that possible, she wants to ask this question. The reporter stated that they don't know what kind of treatment. All her doctors told her shingles was caused by Covod-19 Vaccine, that's why they want to report. The reporter stated that they did not have time and did not have more information for her and would rather like to know answers for all those questions on her behalf. The reporter has was not willing to proceed the call. Limited information available over the call. Outcome of the events were unknown.  The lot number for the vaccine, (BNT162B2), was not provided and will be requested during follow up.
woke up with conjunctivitis in both eyes; nausea; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), CONJUNCTIVITIS (woke up with conjunctivitis in both eyes) and NAUSEA (nausea) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination.     Concurrent medical conditions included High cholesterol.    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm) and NAUSEA (nausea). On 11-Apr-2021, the patient experienced CONJUNCTIVITIS (woke up with conjunctivitis in both eyes). At the time of the report, PAIN IN EXTREMITY (sore arm), CONJUNCTIVITIS (woke up with conjunctivitis in both eyes) and NAUSEA (nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided.  No treatment information was reported.
death Nontraumatic intracranial hemorrhage, unspecified Hemorrhagic cerebrovascular accident (CVA)
Mild to moderate pain behind left ear; spasms in left ocular area; This is a spontaneous report from a contactable healthcare professional.  A 46-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number EL3247), via an unspecified route of administration in the right arm on 19Jan2021, at 11:15 as single dose for covid-19 immunization.  Medical history included Raynaud's from an unknown date, but otherwise healthy. No allergies to medications, food, or other products were noted.  Concomitant medication included acetaminophen (MANUFACTURER UNKNOWN), ascorbic acid, biotin, calcium pantothenate, cyanocobalamin, folic acid, nicotinic acid, pyridoxine hydrochloride, riboflavin, thiamine hydrochloride, tocopheryl acetate (MULTIVITAMIN), both on unspecified dates within 2 weeks of vaccination.  The patient previously received  BNT162B2 on 29Dec2020  for covid-19 immunization  in the left arm, when the patient was 46 years old. The patient experienced mild to moderate pain behind left ear on 19Jan2021, at 18:00 with outcome of recovering; spasms in left ocular area on 19Jan2021, at  18:00 with outcome of recovering. The events were non-serious and described as mild to moderate pain behind left ear and spasms in left ocular area beginning approximately 6-8 hours post injection. Continuing, but lessening frequency and intensity. No therapeutic measures were taken as results of the events.  Prior to vaccination, the patient was not diagnosed with COVID-19; since the vaccination, the patient  has not been tested for COVID-19. The outcome of mild to moderate pain behind left ear was recovering.
tiredness; This case was reported by a consumer via call center representative and described the occurrence of tiredness in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 13th February 2020 16:00, the patient received the 1st dose of Shingrix. In February 2020, 19 hrs after receiving Shingrix, the patient experienced tiredness. On an unknown date, the outcome of the tiredness was unknown.   It was unknown if the reporter considered the tiredness to be related to Shingrix.  Additional information was provided as follows: The age at vaccination was not reported. The vaccine was lasted a full dose. Patient reported that she got her dose of Shingrix at 4 pm. At 11 am, the next day the patient started experiencing tiredness. The reporter did not consent to follow up.
I took a rapid test Monday morning when I got to work, and it was positive. I had no symptoms at the time but was required to test every week by my employer. About noon I was very tired and by Tuesday I was still very tired and congested. I made a telehealth appointment and was prescribed PAXLOVID by the doctor. I started the medication on Wednesday through Sunday. My symptoms improved by the following Monday. I was at about 70% and currently I am at about a 95% recovered. I am still experiencing brain fog but my energy is back to normal.
Flu shot given Tues 11/16/10 in left arm. Patient developed left arm weakness and tingling in thumb and 2nd finger of left hand and arm pain and weakness Wednesday 11/17/10 at 9pm physical at 8 am on 11/19/10 has positive weakness and positive tinnitus.
This is a spontaneous case, initially received from other health professional on 08-Nov-2018, concerning a 02-year-old male child patient. The patient had no medical history and concomitant medications. On 08-Nov-2018, the patient (under 4 years) was administered FLUCELVAX QIVc [dose: 0.5 ml, route of administration: intramuscular, anatomical location: vastus lateralis (thigh) (as reported), batch number: 252661 and expiry date: 31-May-2019], in vastus lateralis of thigh region. The patient did not experience any adverse event after vaccination. The reporter assessed the case as non-serious. Non-significant follow-up received from other health professional on 28-Nov-2018: The reporter confirmed that, the patient did not experience any adverse events.
After having the first 2 Hep B shots, her hair began to fall out.  We had no idea that the vaccine could be causing this, and so we followed with the last shot on 2/10/98.  From around Oct. 1997 through May 1998, her hair continued to fall out.  A dermatologist diagnosed her with alopecia areata.  Months of treatment followed, including cortisone shots in her head in the bald places.  We also used special shampoos & treatments for the alopecia.  In addition, I must add that the emotional trauma that this caused was intense.  Around June of 1998, her hair stared growing back.  She recovered and has not had another incidence of alopecia since then.
PHARMACIST ADMINISTERED VACCINE, PATIENT BEGAN TO FEEL LIGHT HEADED AND DIZZY SO PHARMACIST LAID HER DOWN, ELEVATED HER LEGS AND  BP WAS TAKEN (NORMAL), PLACED AN ICE PACK IN BACK OR HER NECK AND FANED HER AT WHICH SHE BEGAN TO FEEL BETTER, AFTER A FEW MINUTES SHE SAT DOWN AND DIZZINESS CAME BACK, BP WAS TAKEAN AND IT WAS LOW AGAIN, LAID HER BACK DOWN ELEVATED HER LEGS AGAIN, ICE PACK AGAIN, BP WAS TAKEN AND IT WAS NORMAL AGAIN , SHE SAT DOWN AND DIZZINESS CAME BACK, LAID HER DPWN AGAIN, ELEVATED LEGS, ICE PACK IN HER NECK, BP WAS WE NORMAL, STABILIZED HER AND CALLED RESCUE
In May, diarrhea for two weeks up to 10 times a day and  and gastroenterologist and pancreatic insufficiency. No weight loss, No pain and nothing else.
1) Headache days 3-14 2) Vertigo days 4-18 3) Generalized edema, 15# wt gain 5-present day 8 vaccinia 6x4, hot and indurated with blisters on dorsum feet 4) shortness of breath, couldn't do stairs days 5-18 5) chest pain, and tenderness along carotids, days 5-12 6) new blood pressure elevation: d6 210/110, d8, 210/110, d9 170/110 (dyazide), d10 150/96 (dyazide and cozaar), d18 134/80 (dyazide and cozaar), d21 130/80 (no meds)
Was informed by parent that child was walking to main hospital building and fainted. Rapid Response Team at hospital call and child taken to ER for evaluation.
Tinnitus with onset the next day after first injection.  Hissing sound in both ears.  Has lasted 5 1/2 weeks so far.   Some days it is barely noticeable and other days it is very distracting and causes anxiety.
Bad headache, fever and body aches wouldn't stop then I had my first ever shingles outbreak starting 4/16
15 minutes post 1st Pfizer injection patient became nauseated, and started vomiting,  cold clammy finges and feet tingling .  1 hours post injection patient drank water and began vomiting again .  Patient was transported via ambulance to ED for further evaluation.
Patient under the recommended age of 18 received the first dose; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Patient under the recommended age of 18 received the first dose) in a 16-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Patient under the recommended age of 18 received the first dose). On 11-Mar-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Patient under the recommended age of 18 received the first dose) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not provided. Treatment information was not reported.
pt recvd vax 5DEC93; pt exp fever on 6MAR93 & was hospitalized; blood culture on 7MAR pos for H. influenzae (type unk); LP & urine culture neg; pt has cellulitis or r. cheek; rx'd w/IV rocephin; 8MAR stable condition;
fever > 100* f decreased appetite dry mouth, mucus membranes  All > 2 days
Information has been received from a physician concerning a female pt who was vaccinated with varicella virus vaccine live. Subsequently, the pt experienced a rash that was diagnosed to be varicella. No further info was available. Additional info has been requested.
FEVER; This spontaneous report received from a patient concerned a male of unspecified age. The patient's height, and weight were not reported. The patient's past medical history included leukemia, and bone marrow transplant, and concurrent conditions included asthma. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805031, and batch number: 1805031 expiry: UNKNOWN) dose was not reported, administered on 10-MAR-2021 on left arm for prophylactic vaccination. No concomitant medications were reported. On 10-MAR-2021, the subject experienced fever. On 18-MAR-2021, Laboratory data included: Body temperature (NR: not provided) 101 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from fever. This report was non-serious.
felt like she couldn't swallow; chest heaviness; weird sensation on her tongue; felt like it was kind of hard to breathe; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of DYSPHAGIA (felt like she couldn't swallow), CHEST DISCOMFORT (chest heaviness), PARAESTHESIA ORAL (weird sensation on her tongue) and DYSPNOEA (felt like it was kind of hard to breathe) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included GERD, COPD exacerbation and Postnasal drip.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced DYSPHAGIA (felt like she couldn't swallow), CHEST DISCOMFORT (chest heaviness), PARAESTHESIA ORAL (weird sensation on her tongue) and DYSPNOEA (felt like it was kind of hard to breathe). The patient was treated with DEXAMETHASONE ongoing since an unknown date for Adverse event, at a dose of UNK dosage form; PREDNISONE (oral) for Adverse event, at a dose of UNK dosage form; DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at a dose of UNK dosage form; FAMOTIDINE (PEPCID [FAMOTIDINE]) for Adverse event, at a dose of UNK dosage form and ALBUTEROL SULFATE for Adverse event, at a dose of UNK dosage form. On 28-Jan-2021, DYSPHAGIA (felt like she couldn't swallow), CHEST DISCOMFORT (chest heaviness), PARAESTHESIA ORAL (weird sensation on her tongue) and DYSPNOEA (felt like it was kind of hard to breathe) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications include medicines for blood pressure, GERD, and rescue inhaler for her COPD.
Right arm, severe pain, red raised knot at the injection site, approx. size of knot is baseball. Pain is ongoing hurts to move arm, feels like sharp stabbing pain all the way to the bone of the arm/muscle area. Hard to lift or move arm. This has been going on constantly since the shot was given. Unable to sleep at night. Pain has not subsided and it is now 3/30/18.
Severe respiratory illness and worsening asthma within 24 hours of administration of the vaccine.
This spontaneous report was received from a physician, via a company representative, concerning to a patient of unknown age and gender. No concurrent conditions, medical history or concomitant medication were reported. On 17-DEC-2015, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 with lot # L007720 Expiration date: 08-JUL-2018, 0.5 ml (route and anatomical location of administration were not reported). On unspecified dates, the PNEUMOVAX 23 had five temperature excursions of 0 Celsius Degrees (32 Fahrenheit) for 168 hours, 0.55 Celsius Degrees (33 Fahrenheit) for 128 hours, -1.11 Celsius Degrees (30 Fahrenheit) for 264 hours, -1.66 Celsius Degrees (29 Fahrenheit) for 256 hours, and -0.55 Celsius Degrees (31 Fahrenheit) for 368 hours, respectively. The vaccine status was reported as "in excursion" and the type of excursion and storage criteria were reported as "refrigerator(R)". No adverse effects were reported nor Product Quality Complaint (PQC) was involved. This is one of several cases received from the same reporter. Additional information has been requested.
This spontaneous report was received from a medical assistant and refers to an unspecified number of patients of unknown demographics. No information regarding the patients' pertinent medical history, concomitant medications, drug reactions or allergies was provided. On unknown dates in 2017, the patients were possibly vaccinated with improperly stored stoses of GARDASIL 9 injection, lot # M034780 with expiration date 15-APR-2019 (dose, route and site of administration were not reported). GARDASIL 9 was stored between 32 and 35 degrees Fahrenheit for 11 hours and 5 minutes, and between 47 and 77 degrees Fahrenheit for 40 minutes. There was previous temperature excursion. The digital data logger was involved in recording the excursion. There was no product quality complaint involved in this case. This is one of several reports received from the same reporter. Additional information has been requested.; Sender's Comments:  US-009507513-1705USA015617: US-009507513-1705USA015615: US-009507513-1705USA015613: US-009507513-1705USA015612: US-009507513-1705USA015614:
experienced nerve pain on past injuries from a torn rotor cuff from 3 yrs. ago; a very sharp intense sciatic pain from piriformis syndrome; tenderness in my mouth from cementifying fibromas dx'd in the 1970's; numbness on my left thumb at tip; tenderness on my left temple area from a concussion in the 1970's; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 70 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administered in arm right, administration date 25Jan2022 12:00 (Lot number: FJ6369) at the age of 70 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Known allergies: sulfa" (unspecified if ongoing), notes: Verbatim:Known allergies: sulfa; "past injuries" (unspecified if ongoing), notes: Verbatim: Past injuries from a torn rotor cuff from 3 yrs; "cementifying fibromas", start date: 1970 (unspecified if ongoing), notes: tenderness in my mouth from cementifying fibromas dx'd in the 1970's; "concussion", start date: 1970 (unspecified if ongoing), notes: Verbatim:Tenderness on my left, temple area from a concussion in the, 1970's. The patient took concomitant medications. Vaccination history included: Bnt162b2 (Dose 2, Single, 09:00 AM; Intramuscular; Batch/Lot No: FA7484, Location of injection: Arm Right), administration date: 20Aug2021, when the patient was 70 years old, for Covid-19 Immunization; Bnt162b2 (Dose 1, Single, 09:00 AM; Intramuscular; Batch/Lot No: FA7484, Location of injection: Arm Right), administration date: 30Jul2021, when the patient was 70 years old, for Covid-19 Immunization.  The following information was reported: NEURALGIA (non-serious) with onset 26Jan2022 06:00, outcome "not recovered", described as "experienced nerve pain on past injuries from a torn rotor cuff from 3 yrs. ago"; PIRIFORMIS SYNDROME (non-serious) with onset 26Jan2022 06:00, outcome "not recovered", described as "a very sharp intense sciatic pain from piriformis syndrome"; ORAL PAIN (non-serious) with onset 26Jan2022 06:00, outcome "not recovered", described as "tenderness in my mouth from cementifying fibromas dx'd in the 1970's"; HYPOAESTHESIA (non-serious) with onset 26Jan2022 06:00, outcome "not recovered", described as "numbness on my left thumb at tip"; HEADACHE (non-serious) with onset 26Jan2022 06:00, outcome "not recovered", described as "tenderness on my left temple area from a concussion in the 1970's". Therapeutic measures were not taken as a result of neuralgia, piriformis syndrome, oral pain, hypoaesthesia, headache.  Additional information: Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with Covid-19 prior to vaccination. The patient has not been tested for Covid-19 since the vaccination. Patient received other medications within 2 weeks of vaccination. Facility where the most recent COVID-19 vaccine was administered was reported as Pharmacy. Patient did not experience covid-19 prior to vaccination. Patient did not tested post vaccination.  No follow-up attempts are possible. No further information is expected.
Headache; body chills; body fatigue; arm soreness; joint pain; This is a spontaneous report from a contactable other health care professional (patient). A 22-years-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, lot number: EN6201, patient was 22-year-oldand not pregnant at the time of vaccination), via an unspecified route of administration, administered in Arm Left on 13Feb2021 at 01:15 PM as DOSE 2, SINGLE for covid-19 immunisation. Medical history reported as no. The patient's concomitant medications were not reported. Historical vaccine included first dos of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, lot number: EL8982, patient was 22-year-old and not pregnant at the time of vaccination), via an unspecified route of administration, administered in Arm Left on 13Feb2021 at 01:00 PM as DOSE 1, SINGLE for covid-19 immunisation. No other vaccine received in four weeks. No other medications received in two weeks. No covid prior vaccination and not tested covid post vaccination. No known allergies reported. On 13Feb2021 at 08:00 PM, the patient experienced headache, body chills, body fatigue, arm soreness, joint pain. No treatments were received for events. No Seriousness were reported. The outcomes of events were recovered on an unspecified date in 2021.  Follow-up (12May2021): Follow-up attempts completed. No further information expected.
Pt reports Sx's began later Friday, same day after receiving COVID and FLU vaccine. Pt reports a loss of appetite,  fever chill, body aches. Pt reports all Sx's have subsided since, however still experiencing night sweats x 3 days.
Patient reported continued arm pain since 10/3/2018. She went to her physician reporting that she has not been able to lift her arm since the vaccine. The physician recommended physical therapy.
Really bad chills and boast aches with fever.  5 days later shingles with rash under right breast and severed back pain plus uti